The ICAD Principles: From FAIR Data to Decisions at Scale

Scientific data in pharmaceutical R&D is subject to increasing expectations around integrity, traceability, and reproducibility. The FAIR principles established a widely adopted standard for data quality—ensuring that data is findable, accessible, interoperable, and reusable.

However, FAIR defines what data should be—not how it is used.

As a result, many organizations remain unable to consistently transform instrument data into reliable, decision-ready outputs. Data is captured, but not connected. Accessible, but not contextualized. Available, but not operational.

ICAD: From Data to Decisions

The ICAD Principles—Integrate, Contextualize, Analyze, Decide—define the operational sequence required to transform scientific data into decision-ready intelligence.

ICAD is not a checklist. It is a dependent, compounding framework. Each stage builds on the one before it, and the sequence cannot be reordered or skipped without compromising the outcome.

• Integrate: Ensure that data is captured at the point of generation with full provenance.
• Contextualize: Links that data to its scientific meaning—method, sample, study, and program.
• Analyze: Operates only on this governed, contextualized data, ensuring consistency and reproducibility.
• Decide: Builds on this foundation, enabling traceable conclusions and, where appropriate, AI-supported actions.

This structure shifts scientific data from isolated records to a continuous, governed system—where each new data source increases the value of the whole

Why ICAD Is Required

Without a defined operational framework, scientific data remains fragmented across instruments, systems, and sites. Provenance is often incomplete, context is inconsistently applied, and analytical outputs require manual validation before they can be trusted.

These limitations are not technical edge cases—they are systemic. They prevent reliable cross-program analysis, slow down investigations, and introduce risk in regulatory environments where traceability and reproducibility are required.

ICAD addresses these constraints by defining how data moves through the system. It ensures that each step—capture, context, analysis, and decision—is governed as part of a single, connected process rather than independent workflows.

Toward Decision-Ready Scientific Data

As data volumes increase and analytical methods evolve toward AI-supported workflows, the requirements for structured, traceable data systems become more stringent.

Models and analytical frameworks depend on data that is not only accessible, but fully contextualized and governed. Without this foundation, outputs may be statistically valid but scientifically unreliable.

ICAD provides the operational structure required to support these demands—enabling data to be consistently interpreted, compared, and used across programs, sites, and regulatory contexts.

Download the Full ICAD Principles

The ICAD Principles publication provides a detailed specification of this framework, including technical requirements, implementation considerations, and domain-specific examples across pharmaceutical R&D.